Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,133

Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

for

Urothelial Carcinoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07789119

Recruiting

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

for

Intracranial Venous Blood, Brain Cancers, Liquid Biopsy,

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07467109

Recruiting

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

for

Myeloid Leukemia

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06235801

Phase 1, Phase 2, Recruiting

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

for

Pulmonary Disease, Chronic Obstructive

Location: Humble TX, Huntsville TX, Lake Charles LA, Doral FL,

Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT07780669

Phase 3, Recruiting

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

for

COPD (Chronic Obstructive Pulmonary Disease)

Location: Houston TX, Kingwood TX, North Richland Hills TX,

Sponsor: Sanofi

Sex: All

Age: 40+

Code: NCT07612878

Recruiting

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for

Crohn's Disease, Ulcerative Colitis

Location: Bellaire TX, Houston TX, Webster TX, Shenandoah TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase 2, Recruiting

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

for

Chronic Lymphocytic Leukemia (CLL)

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07508995

Phase 2, Recruiting

Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

for

Gastric Cancer, Metastatic

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07509008

Phase 1, Phase 2, Recruiting

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

for

Tumor, Liver

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07444645

Recruiting

Postoperative Pain After Pediatric Adenotonsillectomy With Ketorolac or Ibuprofen

for

Sleep, Pediatrics, Adenotonsillectomy

Location: Houston TX

Sponsor: Baylor College of Medicine

Sex: All

Age: 13 - 18

Code: NCT07672418

Recruiting

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

for

Type 2 Diabetes, Cardiovascular Risk

Location: Houston TX, Sugar Land TX, Katy TX, Conroe TX,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 45+

Code: NCT07797335

Phase 3, Recruiting

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

for

Locally Recurrent Skin Squamous Cell Carcinoma,

Location: Houston TX, Oklahoma City OK, Birmingham AL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07042295

Phase 2, Recruiting

Spatial Computing With the Apple Vision Pro in Image-guided Procedures

for

Apple Vision Pro, Image Guided Procedure, Spatial Computing

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07819513

Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for

Atrial Fibrillation (AF)

Location: Houston TX, Missouri City TX, Tyler TX, West Monroe LA,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase 3, Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for

Small Cell Lung Cancer (SCLC ),

Location: Houston TX, Dallas TX, Nashville TN, St Louis MO,

Sponsor: Moonlight Bio, Inc

Sex: All

Age: 18+

Code: NCT07488923

Phase 1, Recruiting

Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study

for

Neuropathy;Peripheral

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06121232

Recruiting

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

for

Phase 1, NK Cell, IL13Ra, EGFRvIII,

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07579208

Phase 1, Recruiting

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

for

Human Papilloma Virus (HPV),

Location: Houston TX, Pearland TX, Little Rock AR, Mobile AL,

Sponsor: Daré Bioscience, Inc.

Sex: Female

Age: 22 - 50

Code: NCT07601074

Phase 2, Recruiting

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

for

Ann Arbor Stage III Grade 1 Follicular Lymphoma,

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04404088

Phase 2, Recruiting

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

for

Neoplasm Metastasis, Non-Small Cell Lung Cancer

Location: Houston TX, Dallas TX, Birmingham AL, Nashville TN,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT04886804

Phase 1, Recruiting

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City

Paid Clinical Trials Houston

Filter results

Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

Interested in new trials?

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

Postoperative Pain After Pediatric Adenotonsillectomy With Ketorolac or Ibuprofen

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Spatial Computing With the Apple Vision Pro in Image-guided Procedures

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)